Coloplast Corp. has asked the Judicial Panel on Multidistrict Litigation (“JPML”) to consolidate and transfer all federal cases involving its pelvic mesh device to the U.S. District Court for the Southern District of West Virginia for coordinated pretrial proceeding (known as In re Coloplast Corp’s Pelvic Support System Product Liability […]
Category: Mass Torts
You may recall we reported on June 4 that Ethicon, a division of Johnson & Johnson (J&J), announced it was removing four synthetic vaginal meshes from the market – all fall under the Gynecare division – the TVT Secur, Prosima, Prolift and the Prolift+M. An Ethicon spokesman did not call […]
It used to be that the arms industry was the bad boy of all industries. Move over! Big Pharma has now topped the gun trade with a $3 billion fine imposed on GlaxoSmithKline (GSK). Britain’s largest pharmaceutical company, GSK, was just busted for offering lavish incentives to doctors to promote […]
The New England Journal of Medicine published a study on June 20 by John Wei, MD, a researcher and professor of urology at the University of Michigan in Ann Arbor. “What we found is that by putting in a sling, the risk of having leakage is halved,” he said in a […]
If a medical device such as a metal-on-metal (MoM) hip or synthetic vaginal mesh go bad in a patient, the current system has no way of identifying and tracking that medical device. There is no national registry in the U.S. as there is in Britain and Australia, so the recipient of the device gone […]
On July 4, 2012, Stryker posted on its website a national recall of its Rejuvenate and ADM hip implant systems. It’s obvious that Stryker has received far too many reports of shockingly premature failures of its hip implant. The Rejuvenate has only been on the market since 2009 so enough […]
It is estimated that about 500,000 patients have received metal-on-metal hips, though firm numbers are hard to come by because the U.S. does not track medical device implants. In fact, that mystery is just one of many that surfaced on June 27 and 28, when the Food and Drug Administration (FDA) convened […]
Documents recently posted to the FDA’s website say pharmaceutical company, Amylin, has not been completely forthcoming about its diabetes drug, Byetta, and related drug Bydureon, concerning their potential for cardiovascular complications. The active ingredient is the same in the two drugs which are both used to treat type 2 diabetes. However, Bydureon […]
(It Doesn’t Really Matter As Long As Patients and Surgeons Stop Buying the Defective Implants!) While it would certainly be nice to have a government that moved swiftly to recall defective drugs and medical devices from the market, we do not live in that world – at least in the […]
Two new lawsuits were filed this week against Bayer Corporation by Cal Warriner and Brenda Fulmer on behalf of clients from Oregon. The first lawsuit involves a 37 year old single woman employed in the accounting industry from Portland, Oregon. She ingested both Yaz and Gianvi for less than a year […]
